Basic Information
Novel351k provides solutions for biosimilars available in the market. The founding principle of Novel351k is to establish an organization and culture focused on innovation, developing biosimilars by reducing drug costs in the healthcare sector. Novel351k's strategy accelerates drug innovation, development, and commercialization by providing affordable life-changing biologics while improving patients' quality of life.
Novel351k
Chicago,Illinois,United States of America
less than 15 people
--
info@351k.com

